Related references
Note: Only part of the references are listed.Bariatric surgery for morbid obesity in craniopharyngioma
Dirk Weismann et al.
CLINICAL ENDOCRINOLOGY (2013)
Treatment of Hypothalamic Obesity with Caffeine and Ephedrine
Frank Greenway et al.
Endocrine Practice (2013)
GLP-1 Neurons in the Nucleus of the Solitary Tract Project Directly to the Ventral Tegmental Area and Nucleus Accumbens to Control for Food Intake
Amber L. Alhadeff et al.
ENDOCRINOLOGY (2012)
Hypothalamic obesity in children
A. Bereket et al.
OBESITY REVIEWS (2012)
Hypothalamic obesity in patients with craniopharyngioma: treatment approaches and the emerging role of gastric bypass surgery
Gabrielle Page-Wilson et al.
PITUITARY (2012)
Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials
Tina Vilsboll et al.
BMJ-BRITISH MEDICAL JOURNAL (2012)
A Treasure Trove of Hypothalamic Neurocircuitries Governing Body Weight Homeostasis
Claudia R. Vianna et al.
ENDOCRINOLOGY (2011)
Post-operative hypothalamic lesions and obesity in childhood craniopharyngioma: results of the multinational prospective trial KRANIOPHARYNGEOM 2000 after 3-year follow-up
Hermann L. Mueller et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2011)
Neurosurgical treatment of craniopharyngioma in adults and children: early and long-term results in a large case series
Pietro Mortini et al.
JOURNAL OF NEUROSURGERY (2011)
GLP-1 and energy balance: an integrated model of short-term and long-term control
Jason G. Barrera et al.
NATURE REVIEWS ENDOCRINOLOGY (2011)
Is the GLP-1 system a viable therapeutic target for weight reduction?
Jenny Tong et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2011)
Effects of Exenatide Combined with Lifestyle Modification in Patients with Type 2 Diabetes
Caroline M. Apovian et al.
AMERICAN JOURNAL OF MEDICINE (2010)
Effects of Exenatide and Lifestyle Modification on Body Weight and Glucose Tolerance in Obese Subjects With and Without Pre-Diabetes
Julio Rosenstock et al.
DIABETES CARE (2010)
Reduced Energy Expenditure and Impaired Feeding-Related Signals But Not High Energy Intake Reinforces Hypothalamic Obesity in Adults with Childhood Onset Craniopharyngioma
Helene Holmer et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Dopamine Uptake Inhibitors but Not Dopamine Releasers Induce Greater Increases in Motor Behavior and Extracellular Dopamine in Adolescent Rats Than in Adult Male Rats
Q. David Walker et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Hypothalamic involvement predicts cardiovascular risk in adults with childhood onset craniopharyngioma on long-term GH therapy
Helene Holmer et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2009)
The Extrapancreatic Effects of Glucagon-Like Peptide-1 and Related Peptides
Rania Abu-Hamdah et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trial
Alan Garber et al.
LANCET (2009)
Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study
Arne Astrup et al.
LANCET (2009)
Central Control of Body Weight and Appetite
Stephen C. Woods et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Long term pharmacotherapy for obesity and overweight: updated meta-analysis
Diana Rucker et al.
BMJ-BRITISH MEDICAL JOURNAL (2007)
The physiology of glucagon-like peptide 1
Jens Juul Holst
PHYSIOLOGICAL REVIEWS (2007)
Gastric bypass surgery for treatment of hypothalamic obesity after craniopharyngioma therapy
Thomas H. Inge et al.
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM (2007)
Methylphenidate (ritalin): Behavioral studies in the rat
Erik P. Askenasy et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2007)
Craniopharyngiomas
Niki Karavitaki et al.
ENDOCRINE REVIEWS (2006)
The clinical, metabolic and endocrine features and the quality of life in adults with childhood-onset craniopharyngioma compared with adult-onset craniopharyngioma
P Kendall-Taylor et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2005)
Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long-term follow-up
N Karavitaki et al.
CLINICAL ENDOCRINOLOGY (2005)
High prevalence of long-term cardiovascular, neurological and psychosocial morbidity after treatment for craniopharyngioma
AM Pereira et al.
CLINICAL ENDOCRINOLOGY (2005)
Endocrine and neuroanatomic features associated with weight gain and obesity in adult patients with hypothalamic damage
C Daousi et al.
AMERICAN JOURNAL OF MEDICINE (2005)
The role of central glucagon-like peptide-1 in mediating the effects of visceral illness: Differential effects in rats and mice
JL Lachey et al.
ENDOCRINOLOGY (2005)
Use and abuse of HOMA modeling
TM Wallace et al.
DIABETES CARE (2004)
GLP-1 and extra-islet effects
B Ahrén
HORMONE AND METABOLIC RESEARCH (2004)
Octreotide therapy of pediatric hypothalamic obesity: A double-blind, placebo-controlled trial
RH Lustig et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Obesity in patients with craniopharyngioma: Assessment of food intake and movement counts indicating physical activity
KJ Harz et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
The use of dextroamphetamine to treat obesity and hyperphagia in children treated for craniopharyngioma
PW Mason et al.
ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE (2002)
Sympathoadrenal counterregulation in patients with hypothalamic craniopharyngioma
C Schöfl et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
Systemic administration of the long-acting GLP-1 derivative NN2211 induces lasting and reversible weight loss in both normal and obese rats
PJ Larsen et al.
DIABETES (2001)
Association between premature mortality and hypopituitarism
JW Tomlinson et al.
LANCET (2001)
Share Paper
